(Q33588526)

28 July 2017

1 reference

title

Prospects for the therapeutic use of anticancer vaccines (English)

1 reference

28 July 2017

Chamberlain RS

1

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

57

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

309-325

1 reference

GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines

28 July 2017

cites work

1 reference

12 December 2020

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

1 reference

12 December 2020

T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.

1 reference

12 December 2020

Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays

1 reference

12 December 2020

Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.

1 reference

12 December 2020

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

1 reference

12 December 2020

The use of melanosomal proteins in the immunotherapy of melanoma

1 reference

12 December 2020

Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes

1 reference

12 December 2020

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

12 December 2020

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

12 December 2020

Tumor antigens recognized by T lymphocytes

1 reference

12 December 2020

Route of immunization and the therapeutic impact of recombinant anticancer vaccines

1 reference

12 December 2020

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

12 December 2020

Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors

1 reference

12 December 2020

From defined human tumor antigens to effective immunization?

1 reference

12 December 2020

Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

1 reference

12 December 2020

Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma

1 reference

12 December 2020

Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine

1 reference

12 December 2020

Immunotherapy for Malignant Melanoma with a Tumor Cell Vaccine

1 reference

12 December 2020

Antigen processing in vivo and the elicitation of primary CTL responses

1 reference

12 December 2020

1 reference

12 December 2020

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study

1 reference

12 December 2020

Vaccinia recombinants expressing secreted and transmembrane forms of breast cancer-associated epithelial tumour antigen (ETA)

1 reference

12 December 2020

The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).

1 reference

12 December 2020

A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma.

1 reference

12 December 2020

Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line

1 reference

12 December 2020

Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-gamma and tumor necrosis factor

1 reference

12 December 2020

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

12 December 2020

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

12 December 2020

Melanoma patient antibody responses to melanoma tumor-associated antigens defined by murine monoclonal antibodies

1 reference

12 December 2020

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen

1 reference

12 December 2020

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

1 reference

12 December 2020

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

1 reference

12 December 2020

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

12 December 2020

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

12 December 2020

Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.

1 reference

12 December 2020

Recombinant Outer Surface Protein A from Borrelia burgdorferi Induces Antibodies Protective against Spirochetal Infection in Mice

1 reference

12 December 2020

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

1 reference

12 December 2020

Proliferating dendritic cell progenitors in human blood

1 reference

12 December 2020

Adenovirus-Based Expression Vectors and Recombinant Vaccines

1 reference

12 December 2020

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity

1 reference

12 December 2020

The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line

1 reference

12 December 2020

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

1 reference

12 December 2020

Vaccinia virus: a tool for research and vaccine development

1 reference

12 December 2020

Poxvirus-based vectors as vaccine candidates.

1 reference

12 December 2020

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

1 reference

12 December 2020

Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer.

1 reference

12 December 2020

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

12 December 2020

Induction of antitumor immunity using bone marrow-generated dendritic cells

1 reference

12 December 2020

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

12 December 2020

Definition of tumor antigens suitable for vaccine construction

1 reference

12 December 2020

MHC ligands and peptide motifs: first listing

1 reference

12 December 2020

Genetic immunization is a simple method for eliciting an immune response

1 reference

12 December 2020

Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients

1 reference

12 December 2020

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide

1 reference

12 December 2020

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

1 reference

12 December 2020

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

12 December 2020

Direct gene transfer into mouse muscle in vivo

1 reference

12 December 2020

Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.

1 reference

12 December 2020

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

1 reference

12 December 2020

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

12 December 2020

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

1 reference

12 December 2020

Virological evidence for the success of the smallpox eradication programme

1 reference

12 December 2020

Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes

1 reference

12 December 2020

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Interleukin-2 therapy: a decade of slow but steady progress

1 reference

12 December 2020

Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines.

1 reference

12 December 2020

The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

1 reference

12 December 2020

Expression of wild-type and mutant p53 proteins by recombinant vaccinia viruses

1 reference

12 December 2020

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma

1 reference

12 December 2020

Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective

1 reference

12 December 2020

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

12 December 2020

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

1 reference

12 December 2020

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

12 December 2020

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases

1 reference

12 December 2020

Vaccine Trials for the Clinician: Prospects for Viral and Non-Viral Vectors

1 reference

12 December 2020

Tumour prevention and rejection with recombinant vaccinia.

1 reference

12 December 2020

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

12 December 2020

Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

1 reference

12 December 2020

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

1 reference

12 December 2020

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

12 December 2020

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes

1 reference

12 December 2020

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

12 December 2020

New use of BCG for recombinant vaccines

1 reference

12 December 2020

Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses

1 reference

12 December 2020

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

1 reference

12 December 2020

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

12 December 2020

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

12 December 2020

Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma

1 reference

12 December 2020

Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum

1 reference

12 December 2020

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

12 December 2020

Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2

1 reference

12 December 2020

Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action

1 reference

12 December 2020

Induction of antitumor immunity in mice by allo-major histocompatibility complex class I gene transfectant with strong antigen expression

1 reference

12 December 2020

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

12 December 2020

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

12 December 2020

Cytokine gene therapy of cancer.

1 reference

12 December 2020

Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL

1 reference

12 December 2020

Peptide-induced antiviral protection by cytotoxic T cells

1 reference

12 December 2020

Vaccine therapy for cancer

1 reference

12 December 2020

Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene

1 reference

12 December 2020

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21

1 reference

12 December 2020

Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside

1 reference

12 December 2020

Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study

1 reference

12 December 2020

A new look for the 1990s

1 reference

12 December 2020

Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

1 reference

12 December 2020

A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

12 December 2020

Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors

1 reference

12 December 2020

Specific immunotherapy using a recombinant vaccinia virus expressing human carcinoembryonic antigen

1 reference

12 December 2020

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

1 reference

12 December 2020

Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

1 reference

12 December 2020

Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.

1 reference

12 December 2020

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

12 December 2020

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

1 reference

12 December 2020

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

12 December 2020

Treatment of human melanoma with a hapten-modified autologous vaccine

1 reference

12 December 2020

The next wave of recombinant and synthetic anticancer vaccines

1 reference

12 December 2020

The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

1 reference

12 December 2020

Cellular Immunity Against Tumor Antigens

1 reference

12 December 2020

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

1 reference

12 December 2020

Association of HLA phenotype with response to active specific immunotherapy of melanoma

1 reference

12 December 2020

Epitope selection and development of peptide based vaccines to treat cancer

1 reference

12 December 2020

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

12 December 2020

Vaccine Trials for the Clinician: Prospects for Tumor Antigens

1 reference

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

The development of new cancer therapies based on the molecular identification of cancer regression antigens

1 reference

12 December 2020

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition

1 reference

12 December 2020

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues

1 reference

12 December 2020

Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization

1 reference

12 December 2020

Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.

1 reference

12 December 2020

Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

1 reference

12 December 2020

Immunization by direct DNA inoculation induces rejection of tumor cell challenge.

1 reference

12 December 2020

MHC: orchestrating the immune response

1 reference

12 December 2020

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

12 December 2020

Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine

1 reference

12 December 2020

A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine

1 reference

12 December 2020

Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells.

1 reference

12 December 2020

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens

1 reference

12 December 2020

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1 reference

12 December 2020

Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.

1 reference

12 December 2020

A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity

1 reference

12 December 2020

Transfected mouse melanoma lines that express various levels of human melanoma-associated antigen p97

1 reference

12 December 2020

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

1 reference

12 December 2020

10.2165/00003495-199957030-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1043705378

0 references

1 reference